ID S35C2_MOUSE Reviewed; 364 AA. AC Q8VCX2; DT 16-JAN-2004, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2002, sequence version 1. DT 27-MAR-2024, entry version 141. DE RecName: Full=Solute carrier family 35 member C2; DE AltName: Full=Ovarian cancer-overexpressed gene 1 protein; GN Name=Slc35c2; Synonyms=Ovcov1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Salivary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [2] RP DEVELOPMENTAL STAGE. RX PubMed=12461647; DOI=10.1007/s00335-002-2185-4; RA Leach R.E., Duniec-Dmuchowski Z.M., Pesole G., Tanaka T.S., Ko M.S.H., RA Armant D.R., Krawetz S.A.; RT "Identification, molecular characterization, and tissue expression of RT OVCOV1."; RL Mamm. Genome 13:619-624(2002). RN [3] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006; RA Trost M., English L., Lemieux S., Courcelles M., Desjardins M., RA Thibault P.; RT "The phagosomal proteome in interferon-gamma-activated macrophages."; RL Immunity 30:143-154(2009). RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brown adipose tissue, Heart, Kidney, Lung, Pancreas, Spleen, RC and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: May play an important role in the cellular response to tissue CC hypoxia. May be either a GDP-fucose transporter that competes with CC SLC35C1 for GDP-fucose, or a factor that otherwise enhances the CC fucosylation of Notch and is required for optimal Notch signaling in CC mammalian cells (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane CC {ECO:0000250|UniProtKB:Q9NQQ7}; Multi-pass membrane protein CC {ECO:0000255}. Endoplasmic reticulum-Golgi intermediate compartment CC membrane {ECO:0000250|UniProtKB:Q9NQQ7}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- DEVELOPMENTAL STAGE: Higher expression at embryo stage 7.5 dpc than 11- CC 17 dpc. {ECO:0000269|PubMed:12461647}. CC -!- SIMILARITY: Belongs to the TPT transporter family. SLC35C subfamily. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC018327; AAH18327.1; -; mRNA. DR CCDS; CCDS17074.1; -. DR RefSeq; NP_001239502.1; NM_001252573.1. DR RefSeq; NP_001239503.1; NM_001252574.1. DR RefSeq; NP_659142.1; NM_144893.2. DR RefSeq; XP_006499433.1; XM_006499370.3. DR RefSeq; XP_006499434.1; XM_006499371.3. DR RefSeq; XP_006499435.1; XM_006499372.3. DR RefSeq; XP_006499438.1; XM_006499375.3. DR AlphaFoldDB; Q8VCX2; -. DR SMR; Q8VCX2; -. DR STRING; 10090.ENSMUSP00000104923; -. DR TCDB; 2.A.7.9.8; the drug/metabolite transporter (dmt) superfamily. DR GlyCosmos; Q8VCX2; 1 site, No reported glycans. DR GlyGen; Q8VCX2; 1 site. DR iPTMnet; Q8VCX2; -. DR PhosphoSitePlus; Q8VCX2; -. DR jPOST; Q8VCX2; -. DR MaxQB; Q8VCX2; -. DR PaxDb; 10090-ENSMUSP00000104923; -. DR ProteomicsDB; 256885; -. DR Antibodypedia; 53835; 66 antibodies from 14 providers. DR DNASU; 228875; -. DR Ensembl; ENSMUST00000017808.14; ENSMUSP00000017808.8; ENSMUSG00000017664.17. DR Ensembl; ENSMUST00000109298.8; ENSMUSP00000104921.2; ENSMUSG00000017664.17. DR Ensembl; ENSMUST00000109299.8; ENSMUSP00000104922.2; ENSMUSG00000017664.17. DR Ensembl; ENSMUST00000109300.9; ENSMUSP00000104923.3; ENSMUSG00000017664.17. DR GeneID; 228875; -. DR KEGG; mmu:228875; -. DR UCSC; uc008nxd.2; mouse. DR AGR; MGI:2385166; -. DR CTD; 51006; -. DR MGI; MGI:2385166; Slc35c2. DR VEuPathDB; HostDB:ENSMUSG00000017664; -. DR eggNOG; KOG1443; Eukaryota. DR GeneTree; ENSGT00510000048078; -. DR HOGENOM; CLU_022332_1_3_1; -. DR InParanoid; Q8VCX2; -. DR OMA; CEFKLLT; -. DR OrthoDB; 72049at2759; -. DR PhylomeDB; Q8VCX2; -. DR TreeFam; TF314994; -. DR BioGRID-ORCS; 228875; 4 hits in 76 CRISPR screens. DR ChiTaRS; Slc35c2; mouse. DR PRO; PR:Q8VCX2; -. DR Proteomes; UP000000589; Chromosome 2. DR RNAct; Q8VCX2; Protein. DR Bgee; ENSMUSG00000017664; Expressed in lacrimal gland and 260 other cell types or tissues. DR ExpressionAtlas; Q8VCX2; baseline and differential. DR GO; GO:0005801; C:cis-Golgi network; ISO:MGI. DR GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISO:MGI. DR GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005794; C:Golgi apparatus; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0015297; F:antiporter activity; IBA:GO_Central. DR GO; GO:0036065; P:fucosylation; IDA:MGI. DR GO; GO:0010629; P:negative regulation of gene expression; IDA:MGI. DR GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:MGI. DR GO; GO:0036066; P:protein O-linked fucosylation; IDA:MGI. DR GO; GO:0015786; P:UDP-glucose transmembrane transport; IBA:GO_Central. DR CDD; cd21092; TPT_S35C2; 1. DR InterPro; IPR004853; Sugar_P_trans_dom. DR PANTHER; PTHR11132; SOLUTE CARRIER FAMILY 35; 1. DR PANTHER; PTHR11132:SF238; SOLUTE CARRIER FAMILY 35 MEMBER C2; 1. DR Pfam; PF03151; TPT; 1. DR Genevisible; Q8VCX2; MM. PE 1: Evidence at protein level; KW Glycoprotein; Golgi apparatus; Membrane; Phosphoprotein; KW Reference proteome; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..364 FT /note="Solute carrier family 35 member C2" FT /id="PRO_0000213400" FT TRANSMEM 14..34 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 42..62 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 104..124 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 136..156 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 166..186 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 202..222 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 238..258 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 272..292 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 295..315 FT /note="Helical" FT /evidence="ECO:0000255" FT MOD_RES 335 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:19144319, FT ECO:0007744|PubMed:21183079" FT MOD_RES 336 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9NQQ7" FT CARBOHYD 102 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" SQ SEQUENCE 364 AA; 40302 MW; 334B742A566FB891 CRC64; MGRWALDVAF VWKAALTLGL VLLYYCFSIG ITFYNKWLTK SFHFPLFMTM LHLAVIFLFS ALSRALVQCS SHKARVVLSW TDYLRRVAPT ALATALDVGL SNWSFLYITV SLYTMTKSSA VLFILIFSLI FKLEELRAAL VLVVLLIAGG LFMFTYKSTQ FNVEGFALVL GASFIGGIRW TLTQILLQKA DLGLQNPIDT MFHLQPLMFL GLFPLFAIFE GLHLSTSEKI FRFQDTGLLL WVLGSLLLGG ILAFGLGFSE FLLVSRTSSL TLSIAGIFKE VCTLLLAAHL LGDQISLLNW LGFALCLSGI SLHVALKALH SRGDGGPKPL KSLGSSADLE LLLRSSQQEE EDGEEEYFVT QGQQ //